Axovant Sciences Ltd. (AXON) Takes Another Leg Lower

Go back to Axovant Sciences Ltd. (AXON) Takes Another Leg Lower

Axovant Sciences Ltd. (AXON) Sees Early Weakness After Doubling on IPO Debut

June 12, 2015 9:19 AM EDT

After gaining 99% on its debut, yesterday's hot IPO for Axovant Sciences Ltd. (NYSE: AXON) is down 11% in pre-open trading.

... More

Axovant Sciences Ltd. (AXON) Comes Under Scrutiny Amid IPO Surge

June 11, 2015 11:11 AM EDT

With shares up 74% from today's IPO pricing, some cautious notes are appearing on Axovant Sciences Ltd. (NYSE: AXON). FierceBiotech just ripped the company, noting it was started by a hedge fund manager Vivek Ramaswamy after grabbing an abandoned GlaxoSmithKline Alzheimer drug for a mere... More

Axovant Sciences (AXON) IPO Opens Up 40%

June 11, 2015 9:48 AM EDT

The IPO for Axovant Sciences Ltd. (NYSE: AXON) opened for trading at $20.93 today after pricing 21 million common shares at a price of $15 each, which was the high end of its expected $13 - $15 range.

All of the common shares are being offered by Axovant... More

Axovant Sciences (AXON) IPO Prices at Top End of Range

June 11, 2015 8:58 AM EDT

Axovant Sciences Ltd. (NYSE: AXON) priced its initial public offering of 21,000,000 common shares at a price of $15 per share, the high end of the expected $13-$15 range. Shares are expected to begin trading today on the NYSE under the symbol... More